Evidence map›Paper›PMID 30652628›Full record

ArticleTissue engineering. Part A2019

Preconditioned or IL4-Secreting Mesenchymal Stem Cells Enhanced Osteogenesis at Different Stages.

Tzuhua Lin, Yusuke Kohno, Jhih-Fong Huang, Monica Romero-Lopez, Masahiro Maruyama, Masaya Ueno, Jukka Pajarinen, Karthik Nathan, Zhenyu Yao, Fan Yang and 2 more

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Therapeutic effects of MSCs, genetically modified MSCs, and NFĸB-inhibitor on chronic inflammatory osteolysis in aged mice.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. AnStem cells international · 2021
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Tzuhua Lin1Department of Orthopedic Surgery, Stanford University, Stanford, California.
Yusuke Kohno1Department of Orthopedic Surgery, Stanford University, Stanford, California.
Jhih-Fong Huang1Department of Orthopedic Surgery, Stanford University, Stanford, California.
Monica Romero-Lopez1Department of Orthopedic Surgery, Stanford University, Stanford, California.
Masahiro Maruyama1Department of Orthopedic Surgery, Stanford University, Stanford, California.
Masaya Ueno1Department of Orthopedic Surgery, Stanford University, Stanford, California.
Jukka Pajarinen1Department of Orthopedic Surgery, Stanford University, Stanford, California.
Karthik Nathan1Department of Orthopedic Surgery, Stanford University, Stanford, California.
Zhenyu Yao1Department of Orthopedic Surgery, Stanford University, Stanford, California.
Fan Yang1Department of Orthopedic Surgery, Stanford University, Stanford, California.
Joy Y Wu3Division of Endocrinology, Department of Medicine, Stanford University, Stanford, California.
Stuart B Goodman1Department of Orthopedic Surgery, Stanford University, Stanford, California.
Stanford University · US

Funding

Wear Particle Disease and NF-kappa B SignalingR01AR063717 · NIAMS · STANFORD UNIVERSITY · PI GOODMAN, STUART B · 2012 to 2021
$3.5M
Chemokine Directed Cell Trafficking during Continuous Infusion of Wear ParticlesR01AR055650 · NIAMS · STANFORD UNIVERSITY · PI GOODMAN, STUART B · 2007 to 2016
$3.3M
Customized MSCs to Enhance Healing of Bone DefectsR01AR073145 · NIAMS · STANFORD UNIVERSITY · PI GOODMAN, STUART B · 2018 to 2021
$1.4M
NIAMS NIH HHS R01 AR055650NIAMS NIH HHS R01 AR063717NIAMS NIH HHS R01 AR073145
6 · The paper itself

Abstract

impact statementPathogen-associated molecular patterns, damage-associated molecular patterns, and other noxious stimuli activate macrophages to induce the proinflammatory responses. Modulation of inflammatory macrophages (M1) into an anti-inflammatory tissue repair macrophage (M2) phenotype at the appropriate time optimizes bone remodeling and regeneration. Simulating the proinflammatory stimuli by using preconditioned mesenchymal stem cells (MSCs) at an earlier stage, and alleviate the inflammation by using IL4-secreting MSCs at a later stage could further optimize bone regeneration in chronic inflammatory conditions, including periprosthetic osteolysis.

Indexed as

OsteogenesisAnimalsBiomarkersCell DifferentiationGene Expression RegulationImmunomodulationInflammationInterleukin-4MacrophagesMaleMesenchymal Stem CellsMice, Inbred BALB CBiomarkersInterleukin-4IL4macrophagemesenchymal stem cellsosteogenesispreconditioningwear particles

Identifiers

PMID30652628
PMCPMC6686696
OpenAlexW2910312122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.